These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34905563)

  • 1. Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance.
    Kalam A; Shano S; Khan MA; Islam A; Warren N; Hassan MM; Davis M
    PLoS One; 2021; 16(12):e0261368. PubMed ID: 34905563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What contributes to inappropriate antibiotic dispensing among qualified and unqualified healthcare providers in Bangladesh? A qualitative study.
    Nahar P; Unicomb L; Lucas PJ; Uddin MR; Islam MA; Nizame FA; Khisa N; Akter SMS; Rousham EK
    BMC Health Serv Res; 2020 Jul; 20(1):656. PubMed ID: 32669092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rural community perceptions of antibiotic access and understanding of antimicrobial resistance: qualitative evidence from the Health and Demographic Surveillance System site in Matlab, Bangladesh.
    Chowdhury M; Stewart Williams J; Wertheim H; Khan WA; Matin A; Kinsman J
    Glob Health Action; 2019 Dec; 12(sup1):1824383. PubMed ID: 33040695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' perception of their challenges at work, focusing on antimicrobial resistance: a qualitative study from Bangladesh.
    Darj E; Newaz MS; Zaman MH
    Glob Health Action; 2019; 12(sup1):1735126. PubMed ID: 32131711
    [No Abstract]   [Full Text] [Related]  

  • 5. Perceptions of antibiotic stewardship programmes and determinants of antibiotic prescribing patterns among physicians in tertiary hospitals in Bangladesh: implications for future policy and practice.
    Sumon SA; Anwar MMU; Akther FM; Priyanka AS; Tamanna T; Rahman A; Islam MS; Harun MGD
    J Hosp Infect; 2024 Feb; 144():56-65. PubMed ID: 38070709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital use of antibiotics in internal medicine: A cross-sectional study before, during and after the COVID-19 pandemic in a COVID-19-free ward.
    Bellanti F; Lo Buglio A; Ricci A; Aquilino A; Labbate A; Vendemiale G
    J Infect Public Health; 2024 Aug; 17(8):102490. PubMed ID: 38991413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
    Ghosh S; Bornman C; Zafer MM
    J Infect Public Health; 2021 May; 14(5):555-560. PubMed ID: 33848884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics in the Community During the COVID-19 Pandemic: A Qualitative Study to Understand Users' Perspectives of Antibiotic Seeking and Consumption Behaviors in Bangladesh.
    Kalam MA; Shano S; Afrose S; Uddin MN; Rahman N; Jalal FA; Akter S; Islam A; Anam MM; Hassan MM
    Patient Prefer Adherence; 2022; 16():217-233. PubMed ID: 35115769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pandemic beyond the Pandemic: A Scoping Review on the Social Relationships between COVID-19 and Antimicrobial Resistance.
    Toro-Alzate L; Hofstraat K; de Vries DH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    J Glob Antimicrob Resist; 2021 Jun; 25():5-7. PubMed ID: 33662647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
    Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
    Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of antibiotic use in Bangladesh: qualitative protocol for the PAUSE study.
    Rousham EK; Islam MA; Nahar P; Lucas PJ; Naher N; Ahmed SM; Nizame FA; Unicomb L
    BMJ Open; 2019 Jan; 9(1):e028215. PubMed ID: 30782763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    Trans R Soc Trop Med Hyg; 2021 Oct; 115(10):1122-1129. PubMed ID: 33772597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of current research on COVID-19 and antibiotic use: global implications for antimicrobial resistance.
    Zyoud SH
    J Health Popul Nutr; 2023 May; 42(1):42. PubMed ID: 37173756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defeating the Silent Enemy: Antimicrobial Resistance Looming as the Next Global Pandemic.
    Tiwaskar M; Vora A; Saraf A; Bhadade R; Choudhari S; Pawar D; Sharma A
    J Assoc Physicians India; 2024 Mar; 72(3):66-72. PubMed ID: 38736120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics.
    Ukuhor HO
    J Infect Public Health; 2021 Jan; 14(1):53-60. PubMed ID: 33341485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
    Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA
    PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling Antimicrobial Resistance in the Shadow of COVID-19.
    Patel A
    mBio; 2021 Aug; 12(4):e0047321. PubMed ID: 34281392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
    Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
    J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance and COVID-19: Intersections and implications.
    Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI
    Elife; 2021 Feb; 10():. PubMed ID: 33588991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.